Gene editing patent ruling sways biotech fortunes
Thursday, February 16, 2017 - 12:31
in Biology & Nature
The federal patent office has turned back a challenge to patents on CRISPR, an innovative method for gene editing
The federal patent office has turned back a challenge to patents on CRISPR, an innovative method for gene editing